IP Library › Assignment 042917/0184
Patent Assignment
Reel/Frame 042917/0184

Corrective Assignment to Correct the Assignee and Assignment Document Previously Recorded on Reel 042747 Frame 0283. Assignor(S) Hereby Confirms the Assignment.

Recorded: 2017-06-20 Pages: 9
Assignor
ALLERGAN, INC.
Executed: 2017-05-23
Assignee
REPRISE BIOPHARMACEUTICS, LLC
120 NORTH MAIN STREET, NEW CITY, NEW YORK, 10956
Covered Properties (6)
Pharmaceutical Compositions Including Low Dosages of Desmopressin
Patent: 7,799,761 →
Application: 10/706,100 →
Publication: US 2004/0138098
Pharmaceutical Compositions Including Low Dosages of Desmopressin
Patent: 7,405,203 →
Application: 11/744,615 →
Publication: US 2007/0265207
Pharmaceutical Compositions Including Low Dosages of Desmopressin
Patent: 8,143,225 →
Application: 12/173,072 →
Publication: US 2008/0274951
Pharmaceutical Compositions Including Low Dosages of Desmopressin
Patent: 7,579,321 →
Application: 12/173,074 →
Publication: US 2009/0005432
Pharmaceutical Compositions Including Low Dosages of Desmopressin
Application: 12/613,855 →
Publication: US 2010/0056436
Pharmaceutical Compositions Including Low Dosages of Desmopressin
Application: 13/599,768 →
Publication: US 2012/0322734
Related Assignments (13)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 23, 2008
From: FEIN, SEYMOUR
To: REPRISE PHARMACEUTICALS, LLC
Reel/Frame 020990/0237 →
Corrective Assignment to Correct the Assignee from Reprise Pharmaceuticals, Llc to Reprise Biopharmaceutics, Llc Previously Recorded on Reel 020990 Frame 0237. Assignor(S) Hereby Confirms the Assignment to the Assignee. Jun 19, 2008
From: FEIN, SEYMOUR
To: REPRISE BIOPHARMACEUTICS, LLC
Reel/Frame 021121/0562 →
Assignment of Assignor's Interest Jul 14, 2009
From: FEIN, SEYMOUR
To: REPRISE BIOPHARMACEUTICS, LLC
Reel/Frame 022954/0040 →
Corrective Assignment to Correct the Assignee's City Address Previously Recorded on Reel 022954 Frame 0040. Assignor(S) Hereby Confirms the Assignment Agreement. Aug 21, 2009
From: FEIN, SEYMOUR
To: REPRISE BIOPHARMACEUTICS LLC
Reel/Frame 023128/0258 →
Assignment of Assignor's Interest May 19, 2010
From: REPRISE BIOPHARMACEUTICS, LLC
To: ALLERGAN, INC.
Reel/Frame 024412/0072 →
Assignment of Assignor's Interest Jul 12, 2010
From: FEIN, SEYMOUR
To: REPRISE BIOPHARMACEUTICS LLC
Reel/Frame 024666/0482 →
Assignment of Assignor's Interest Oct 18, 2012
From: REPRISE BIOPHARMACEUTICS, LLC
To: ALLERGAN, INC.
Reel/Frame 029148/0533 →
Assignment of Assignor's Interest Oct 18, 2012
From: FEIN, SEYMOUR
To: REPRISE BIOPHARMACEUTICS, LLC
Reel/Frame 029148/0509 →
Assignment of Assignor's Interest Jun 19, 2017
From: ALLERGAN, INC.
To: SERENITY PHARMACEUTICALS LLC
Reel/Frame 042747/0283 →
Assignment of Assignor's Interest Dec 29, 2021
From: REPRISE BIOPHARMACEUTICS, LLC
To: SERENITY PHARMACEUTICALS LLC
Reel/Frame 058499/0653 →
Change of Name Sep 22, 2022
From: SERENITY PHARMACEUTICALS LLC
To: ACERUS PHARMACEUTICALS USA, LLC
Reel/Frame 061509/0419 →
Security Interest Dec 22, 2022
From: ACERUS PHARMACEUTICALS USA, LLC
To: FIRST GENERATION CAPITAL INC.
Reel/Frame 062185/0506 →
Security Interest Dec 22, 2023
From: ACERUS PHARMACEUTICALS USA, LLC
To: FIRST GENERATION CAPITAL INC.
Reel/Frame 065943/0612 →